CHI cordially invites you to attend its Policy Perspective series. Attend the NuVasive event to hear from California’s top biomedical leaders as they their insights on major industry issues.
Hosted by NuVasive
Questions? Contact Marisa Reinoso, CHI Associate Director – Marketing & Programs (Reinoso@chi.org or 858-456-8890).
Congressman Scott Peters
D-CA 52nd District
Congressman Scott Peters serves California’s 52nd Congressional District, which includes the cities of Coronado, Poway and most of northern San Diego. First elected in 2012, he currently serves on the House committees on Armed Services & on Science, Space, & Technology Committee.
Chief Executive Officer, ResMed Inc.
Michael ‘Mick’ Farrell has been has been Chief Executive Officer for ResMed since March 2013. Prior to that appointment, Mr. Farrell served as President – Americas for ResMed from 2011 to 2013. He was previously senior vice president of the global business unit for sleep apnea therapeutic and diagnostic devices from 2007 to 2011, and before that he held various senior roles in marketing and business development.
Michael A. Narachi
President & CEO, Orexigen Therapeutics
Michael A. Narachi has served as the President and Chief Executive Officer and a member of the board of directors since March 2009. Previously, Mr. Narachi served as Chairman, Chief Executive Officer and President of Ren Pharmaceuticals, Inc., a private biotechnology company, from November 2006 to March 2009.
Keith C. Valentine
Keith C. Valentine has served as President and Chief Operating Officer of NuVasive Inc., the fourth largest spine implant company in the world, since January 2007. NuVasive is regarded as the world leader in minimally disruptive spinal surgery solutions. The company’s innovative products and pioneering spine surgery techniques have catapulted the startup into an industry leader.